Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Orca Bio
Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T
June 05, 2024
From
Orca Bio
Via
Business Wire
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
May 23, 2024
From
Orca Bio
Via
Business Wire
Orca Bio to Present Positive Clinical Data on Orca-T at the 50th Annual Meeting of the EBMT
April 11, 2024
From
Orca Bio
Via
Business Wire
Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
February 23, 2024
From
Orca Bio
Via
Business Wire
Orca Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Orca Bio
Via
Business Wire
Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting
December 09, 2023
From
Orca Bio
Via
Business Wire
Orca Bio to Present Positive Clinical Data on its Novel High-Precision Cell Therapies at the 65th American Society of Hematology Annual Meeting
November 02, 2023
From
Orca Bio
Via
Business Wire
Orca Bio Presents Positive Data Reinforcing Clinical Profile of Orca-T and Orca-Q at 2023 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
February 16, 2023
From
Orca Bio
Via
Business Wire
Orca Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 06, 2023
From
Orca Bio
Via
Business Wire
Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting
December 12, 2022
From
Orca Bio
Via
Business Wire
Orca Bio Presents Data Demonstrating its Lead Investigational High-Precision Cell Therapy Orca-T Significantly Improved Relapse-Free Survival at 64th ASH Annual Meeting
December 10, 2022
From
Orca Bio
Via
Business Wire
Orca Bio to Present Four Abstracts at the 64th American Society of Hematology Annual Meeting, Including Updated Relapse-Free Survival Data with Orca-T and the First Clinical Data for Orca-Q
November 03, 2022
From
Orca Bio
Via
Business Wire
Orca Bio Expands Manufacturing Capabilities to Develop and Commercialize its Precision Cell Therapies
September 08, 2022
From
Orca Bio
Via
Business Wire
Orca Bio Announces the Precision-T Phase 3 Study is Open and Enrolling Patients at Transplant Centers Across the U.S.
August 02, 2022
From
Orca Bio
Via
Business Wire
Orca Bio to Present New Clinical Data on Orca-T at the European Hematology Association 2022 Congress
May 12, 2022
From
Orca Bio
Via
Business Wire
Orca Bio Presents Positive Data Reinforcing Clinical Profile and Manufacturing Reliability of Orca-T at 2022 Transplantation & Cellular Therapy ASTCT and CIBMTR Tandem Meetings
April 25, 2022
From
Orca Bio
Via
Business Wire
Orca Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 06, 2022
From
Orca Bio
Via
Business Wire
Positive Clinical Results from More than 100 Patients Treated with Orca Bio’s Lead Investigational High Precision Cell Therapy Presented at 63rd ASH Annual Meeting
December 11, 2021
From
Orca Bio
Via
Business Wire
Orca Bio to Present New Clinical Data on Orca-T at the 63rd American Society of Hematology Annual Meeting
November 04, 2021
From
Orca Bio
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.